Release date: 2024-07-09 16:12:45 Recommended: 325
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more about the production process and product quality of Lucius Pharmaceuticals.
During his visit, Dr. Luis conducted an in-depth study of Lucius Pharmaceutical's facilities and operational processes. He expressed his high appreciation for the high standards and professionalism of Lucius Pharmaceuticals. "I am very impressed with the facilities and the professionalism of the staff at Lucius Pharmaceuticals," he said. Their commitment to product quality and sense of responsibility to public health is admirable. ”
In addition, Dr. Luis made some valuable suggestions to Lucius Pharmaceuticals to help them further improve product quality and production efficiency. He stressed the importance of continuous improvement and innovation and encouraged Lucius Pharmaceuticals to continue its efforts in this regard.
Overall, Dr. Luis was very satisfied with the technical visit to Lucius Pharmaceuticals. He looks forward to seeing Lucius Pharmaceuticals continue to maintain its high standards in the future and play an even greater role in the global pharmaceutical industry. The visit not only strengthened the WHO's ties with the Lao pharmaceutical industry, but also set a positive example for other pharmaceutical companies.
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended:326Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended:196Release date: 2024-07-09
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) ···【more】
Recommended:154Release date: 2025-01-13
Recent advancements have reaffirmed the significance of liquid biopsy in the man···【more】
Recommended:151Release date: 2025-01-06
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Fo···【more】
Recommended:166Release date: 2024-12-30
The new indication involves the treatment of adult patients with locally advance···【more】
Recommended:157Release date: 2024-12-24
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont···【more】
Recommended:143Release date: 2024-12-17
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-C···【more】
Recommended:104Release date: 2024-12-13
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended:207Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended:220Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended:192Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended:158Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended:290Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended:170Release date: 2024-07-09